Cannabinoids in Nature and MedicineISBN: 978-3-90639-056-7
Hardcover
356 pages
September 2009
|
Originally a special issue of Chemistry & Biodiversity, the
first part of this volume focuses on the plant Cannabis sativa, its
active ingredients, and the discovery of cannabinoid receptors as
well as the therapeutic applications of activating, or blocking,
the receptors. Following an overview of the plant, its medicinal
uses, and its preparations, further chapters cover biosynthetic
pathways, pharmacological properties, cannabis-based medicine,
toxicology, cannabis prohibition and clinical situations where
blocking the cannabinoid receptors might be beneficial.
The second part covers the journey from humans to plants, analyzing anandamide, as well as other endocannabinoids and endocannabinoid congeners, biosynthetic pathways, current knowledge of FAAH-1, FAAH-2, monoglyceride lipase and NAAA, concluding with new areas of research.
The second part covers the journey from humans to plants, analyzing anandamide, as well as other endocannabinoids and endocannabinoid congeners, biosynthetic pathways, current knowledge of FAAH-1, FAAH-2, monoglyceride lipase and NAAA, concluding with new areas of research.